Half of all adults in the UK have now been vaccinated, said Matt Hancock.
The Minister of Health tweeted: “Yesterday we vaccinated more people than ever before. I am happy to say that we have now vaccinated HALF all adults under the UK flag.
“The vaccine is a national success story and our way out of this pandemic. When you get the call, get the push. “
This comes amid fears that the UK’s vaccine supply will slow radically over the next few days and weeks.
In India, four to five million vaccine doses are delayed towards the UK.
1.7 million cans already have to be retested.
And the executive of the European Union has stated that AstraZeneca could face export bans to countries outside the bloc if it does not accelerate the delivery of the promised amount of vaccines.
The move comes as the European Commission increases pressure on pharmaceutical companies to accelerate their vaccine delivery to the continent as virus cases rise in many member countries.
The President of the European Commission, Ursula von der Leyen, said: “We have the possibility to ban planned exports.
“This is a message to AstraZeneca: you do your part of the business with Europe before you start delivering to other countries.”
In an interview with the German media group Funke, Ms. von der Leyen said that the contract between the EU and AstraZeneca clearly regulates how much vaccines the EU receives from AstraZeneca’s plants in the EU and Great Britain.
However, Frau von der Leyen added: “We did not get anything from the British while we were supplying them with vaccines.”
She said the Commission had sent AstraZeneca a “formal reminder” on the matter.
AstraZeneca’s coronavirus vaccine is one of three vaccines approved in the EU.
However, its use has been overshadowed by several issues, including a slow start, recurring delivery issues and a temporary ban for several days earlier this week in many EU member states following reports of blood clots in some recipients of the vaccine.
Most of the countries in the EU resumed AstraZeneca shocks on Friday as infection rates rose across the continent.
The Oxford / AstraZeneca vaccine, cheaper and easier to store than others, is seen as critical in ending the coronavirus pandemic.